Research Focus

Clinical Pipeline

Melanocortin Receptor Programs Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Submission FDA Approval

Vyleesi™ (bremelanotide) MC4r Agonist

Hypoactive Sexual Desire Disorder

PL-8177 MC1r Agonist

Inflammatory Bowel Diseases

PL-8331 MC1/5r Agonist

Anti-inflammatory Ocular Indications

MC4r Agonist Peptide & Small Molecules

Rare Genetic Metabolic and Obesity Disorders

Natriuretic Peptide Receptor Programs Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Submission FDA Approval

PL-3994 NPR-A

Cardiovascular Diseases

PL-5028 NPR-A/C Agonist

Cardiac Hypertrophy and Fibrosis